|
SATB1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65234492754962E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.00470031872658E-10 |
| Normal-vs-Stage2 |
5.401000E-03 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
9.806800E-01 |
| Stage1-vs-Stage3 |
3.16160000002341E-06 |
| Stage1-vs-Stage4 |
3.95539999999972E-05 |
| Stage2-vs-Stage3 |
8.425900E-02 |
| Stage2-vs-Stage4 |
4.200000E-02 |
| Stage3-vs-Stage4 |
3.934000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62903024403249E-12 |
| Normal-vs-AfricanAmerican |
1.820750E-03 |
| Normal-vs-Asian |
3.761900E-02 |
| Caucasian-vs-AfricanAmerican |
1.054020E-02 |
| Caucasian-vs-Asian |
4.082600E-01 |
| AfricanAmerican-vs-Asian |
8.557600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.42472708578134E-13 |
| Normal-vs-Female |
2.16260342966734E-12 |
| Male-vs-Female |
8.014200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.835200E-04 |
| Normal-vs-Age(41-60Yrs) |
2.1311999942597E-09 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
7.24409976449181E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.250200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.292300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.047900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.379900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.879300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.756800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.561600E-02 |
| Normal-vs-Grade 2 |
2.35149999472384E-08 |
| Normal-vs-Grade 3 |
1.62458935193399E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
1.364190E-01 |
| Grade 1-vs-Grade 3 |
1.166370E-02 |
| Grade 1-vs-Grade 4 |
5.771700E-04 |
| Grade 2-vs-Grade 3 |
8.993200E-04 |
| Grade 2-vs-Grade 4 |
2.01689999999033E-05 |
| Grade 3-vs-Grade 4 |
9.174400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
1.50936999999685E-05 |
| ccA subtype-vs-ccB subtype |
6.637200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.72604161466461E-12 |
| Normal-vs-N1 |
1.66239999987994E-07 |
| N0-vs-N1 |
1.633000E-01 |
|
|
